Little House Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Sell |
5,830
-477
| -8% | -$212K | 0.65% | 44 |
|
|
2025
Q1 | $3.06M | Buy |
6,307
+1,573
| +33% | +$763K | 0.84% | 34 |
|
|
2024
Q4 | $1.91M | Buy |
4,734
+1,011
| +27% | +$407K | 0.54% | 48 |
|
|
2024
Q3 | $1.73M | Buy |
3,723
+1,033
| +38% | +$480K | 0.5% | 56 |
|
|
2024
Q2 | $1.26M | Buy |
2,690
+191
| +8% | +$89.5K | 0.39% | 58 |
|
|
2024
Q1 | $1.04M | Buy |
2,499
+179
| +8% | +$74.8K | 0.35% | 71 |
|
|
2023
Q4 | $944K | Buy |
2,320
+859
| +59% | +$350K | 0.34% | 76 |
|
|
2023
Q3 | $508K | Buy |
1,461
+42
| +3% | +$14.6K | 0.21% | 91 |
|
|
2023
Q2 | $499K | Buy |
1,419
+14
| +1% | +$4.93K | 0.21% | 90 |
|
|
2023
Q1 | $443K | Buy |
1,405
+12
| +0.9% | +$3.78K | 0.21% | 93 |
|
|
2022
Q4 | $402K | Sell |
1,393
-14
| -1% | -$4.04K | 0.2% | 90 |
|
|
2022
Q3 | $407K | Buy |
1,407
+23
| +2% | +$6.65K | 0.22% | 88 |
|
|
2022
Q2 | $390K | Sell |
1,384
-331
| -19% | -$93.3K | 0.21% | 92 |
|
|
2022
Q1 | $448K | Buy |
1,715
+108
| +7% | +$28.2K | 0.23% | 105 |
|
|
2021
Q4 | $353K | Buy |
1,607
+292
| +22% | +$64.1K | 0.19% | 113 |
|
|
2021
Q3 | $239K | Buy |
+1,315
| New | +$239K | 0.14% | 129 |
|
|
2021
Q1 | – | Sell |
-1,399
| Closed | -$330K | – | 165 |
|
|
2020
Q4 | $330K | Buy |
+1,399
| New | +$330K | 0.24% | 82 |
|